Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System

Stem Cells and Development

Volumn 24, Issue 24, 2015, Pages 2925-2942

  Li, Shenglan ^a   Xue, Haipeng ^a   Wu, Jianbo ^a   Rao, Mahendra S ^b   Kim, Dong H ^a   Deng, Wenbin ^c,d   Liu, Ying ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b New York Stem Cell Foundation   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRISPR ASSOCIATED PROTEIN; CRISPR ASSOCIATED PROTEIN 9; NEUROGENIN 2; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; NERVE PROTEIN; NEUROG2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CRISPR CAS SYSTEM; CRISPR CAS9 SYSTEM; GENE INDUCTION; GENE LOCUS; GENE TARGETING; GENETIC RECOMBINATION; HOMOLOGY DIRECTED RECOMBINATION; HUMAN; HUMAN CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSIENT EXPRESSION; CELL LINE; CYTOLOGY; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROCEDURES; REPORTER GENE;

BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; CRISPR-CAS SYSTEMS; GENE KNOCK-IN TECHNIQUES; GENES, REPORTER; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS;

EID: 84983121994     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2015.0131     Document Type: Article

References (78)

1. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
2. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
3. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917-1920.
4. Zwaka TP and JA Thomson. (2003). Homologous recombination in human embryonic stem cells. Nat Biotechnol 21:319-321.
5. Davis RP, ES Ng, M Costa, AK Mossman, K Sourris, AG Elefanty and EG Stanley. (2008). Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors. Blood 111: 1876-1884.
6. Ruby KM and B Zheng. (2009). Gene targeting in a HUES line of human embryonic stem cells via electroporation. Stem Cells 27:1496-1506.
7. Xue H, S Wu, ST Papadeas, S Spusta, AM Swistowska, CC MacArthur, MP Mattson, NJ Maragakis, MR Capecchi, et al. (2009). A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells. Stem Cells 27:1836-1846.
8. Liu Y, P Jiang andWDeng. (2011). OLIG gene targeting in human pluripotent stem cells for motor neuron and oligodendrocyte differentiation. Nat Protoc 6:640-655.
9. Hockemeyer D, F Soldner, C Beard, Q Gao, M Mitalipova, RC DeKelver, GE Katibah, R Amora, EA Boydston, et al. (2009). Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 27:851-857.
10. Schinzel RT, T Ahfeldt, FH Lau, YK Lee, A Cowley, T Shen, D Peters, DH Lum and CA Cowan. (2011). Efficient culturing and genetic manipulation of human pluripotent stem cells. PLoS One 6:e27495.
11. Wang P, RT Rodriguez, J Wang, A Ghodasara and SK Kim. (2011). Targeting SOX17 in human embryonic stem cells creates unique strategies for isolating and analyzing developing endoderm. Cell Stem Cell 8:335-346.
12. Goulburn AL, D Alden, RP Davis, SJ Micallef, ES Ng, QC Yu, SM Lim, CL Soh, DA Elliott, et al. (2011). A targeted NKX2.1 human embryonic stem cell reporter line enables identification of human basal forebrain derivatives. Stem Cells 29:462-473.
13. Aizawa E, Y Hirabayashi, Y Iwanaga, K Suzuki, K Sakurai, M Shimoji, K Aiba, T Wada, N Tooi, et al. (2012). Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors. Mol Ther 20:424-431.
14. Brafman DA, N Moya, S Allen-Soltero, T Fellner, M Robinson, ZL McMillen, T Gaasterland and K Willert. (2013). Analysis of SOX2-expressing cell populations derived from human pluripotent stem cells. Stem Cell Reports 1:464-478.
15. Jinek M, K Chylinski, I Fonfara, M Hauer, JA Doudna and E Charpentier. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816-821.
16. Wang H, H Yang, CS Shivalila, MM Dawlaty, AW Cheng, F Zhang and R Jaenisch. (2013). One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153:910-918.
17. Mali P, L Yang, KM Esvelt, J Aach, M Guell, JE DiCarlo, JE Norville and GM Church. (2013). RNA-guided human genome engineering via Cas9. Science 339:823-826.
18. Hwang WY, Y Fu, D Reyon, ML Maeder, SQ Tsai, JD Sander, RT Peterson, JR Yeh and JK Joung. (2013). Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31:227-229.
19. Friedland AE, YB Tzur, KM Esvelt, MP Colaiacovo, GM Church and JA Calarco. (2013). Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods 10:741-743.
20. DiCarlo JE, JE Norville, P Mali, X Rios, J Aach and GM Church. (2013). Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Res 41:4336-4343.
21. Cong L, FA Ran, D Cox, S Lin, R Barretto, N Habib, PD Hsu, X Wu, W Jiang, LA Marraffini and F Zhang. (2013). Multiplex genome engineering using CRISPR/Cas systems. Science 339:819-823.
22. Niu Y, B Shen, Y Cui, Y Chen, J Wang, L Wang, Y Kang, X Zhao, W Si, et al. (2014). Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell 156:836-843.
23. Shaner NC, RE Campbell, PA Steinbach, BN Giepmans, AE Palmer and RY Tsien. (2004). Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22:1567-1572.
24. Yu C, Y Liu, T Ma, K Liu, S Xu, Y Zhang, H Liu, M La Russa, M Xie, S Ding and LS Qi. (2015). Small molecules enhance CRISPR genome editing in pluripotent stem cells. Cell Stem Cell 16:142-147.
25. Chu VT, T Weber, B Wefers, W Wurst, S Sander, K Rajewsky and R Kuhn. (2015). Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol 33:543-548.
26. Xue H, J Wu, S Li, MS Rao and Y Liu. (2016). Genetic modification in human pluripotent stem cells by homologous recombination and CRISPR/Cas9 system. Methods Mol Biol 1307:173-190.
27. Macarthur CC, H Xue, D Van Hoof, PT Lieu, M Dudas, A Fontes, A Swistowski, T Touboul, R Seerke, et al. (2012). Chromatin insulator elements block transgene silencing in engineered human embryonic stem cell lines at a defined chromosome 13 locus. Stem Cells Dev 21:191-205.
28. Sander JD, P Zaback, JK Joung, DF Voytas and D Dobbs. (2007). Zinc finger targeter (ZiFiT): an engineered zinc finger/target site design tool. Nucleic Acids Res 35:W599-W605.
29. Sander JD, ML Maeder, D Reyon, DF Voytas, JK Joung and D Dobbs. (2010). ZiFiT (zinc finger targeter): an updated zinc finger engineering tool. Nucleic Acids Res 38:W462-W468.
30. Li S, H Xue, B Long, L Sun, T Truong and Y Liu. (2015). Efficient generation of hiPSC neural lineage specific knockin reporters using the CRISPR/Cas9 and Cas9 double nickase system. J Vis Exp e52539; DOI: 10.3791/52539.
31. Weber E, R Gruetzner, S Werner, C Engler and S Marillonnet. (2011). Assembly of designer TAL effectors by Golden Gate cloning. PLoS One 6:e19722.
32. Weber E, C Engler, R Gruetzner, S Werner and S Marillonnet. (2011). A modular cloning system for standardized assembly of multigene constructs. PLoS One 6:e16765.
33. Engler C, R Gruetzner, R Kandzia and S Marillonnet. (2009). Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. PLoS One 4:e5553.
34. Guschin DY, AJ Waite, GE Katibah, JC Miller, MC Holmes and EJ Rebar. (2010). A rapid and general assay for monitoring endogenous gene modification. Methods Mol Biol 649:247-256.
35. Ran FA, PD Hsu, J Wright, V Agarwala, DA Scott and F Zhang. (2013). Genome engineering using the CRISPRCas9 system. Nat Protoc 8:2281-2308.
36. Xiao A, Z Cheng, L Kong, Z Zhu, S Lin, G Gao and B Zhang. (2014). CasOT: a genome-wide Cas9/gRNA offtarget searching tool. Bioinformatics 30:1180-1182.
37. Reinhardt P, M Glatza, K Hemmer, Y Tsytsyura, CS Thiel, S Hoing, S Moritz, JA Parga, L Wagner, et al. (2013). Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS One 8:e59252.
38. Swistowski A, J Peng, Y Han, AM Swistowska, MS Rao and X Zeng. (2009). Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them. PLoS One 4:e6233.
39. Liu Y, SS Han, Y Wu, TM Tuohy, H Xue, J Cai, SA Back, LS Sherman, I Fischer and MS Rao. (2004). CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol 276:31-46.
40. Fu Y, JD Sander, D Reyon, VM Cascio and JK Joung. (2014). Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat Biotechnol 32:279-284.
41. Liu Y, Y Wu, JC Lee, H Xue, LH Pevny, Z Kaprielian and MS Rao. (2002). Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development. Glia 40:25-43.
42. Ma YC, MR Song, JP Park, HY Henry Ho, L Hu, MV Kurtev, J Zieg, Q Ma, SL Pfaff and ME Greenberg. (2008). Regulation of motor neuron specification by phosphorylation of neurogenin 2. Neuron 58:65-77.
43. Fu Y, D Reyon and JK Joung. (2014). Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs. Methods Enzymol 546:21-45.
44. Capecchi MR. (2005). Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 6:507-512.
45. Folger KR, EA Wong, G Wahl and MR Capecchi. (1982). Patterns of integration of DNA microinjected into cultured mammalian cells: evidence for homologous recombination between injected plasmid DNA molecules. Mol Cell Biol 2:1372-1387.
46. Bae S, J Park and JS Kim. (2014). Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30:1473-1475.
47. Kim D, S Bae, J Park, E Kim, S Kim, HR Yu, J Hwang, JI Kim and JS Kim. (2015). Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods 12:237-243.
48. Wang X, Y Wang, X Wu, J Wang, Y Wang, Z Qiu, T Chang, H Huang, RJ Lin and JK Yee. (2015). Unbiased detection of off-target cleavage by CRISPR-Cas9 and TALENs using integrase-defective lentiviral vectors. Nat Biotechnol 33:175-178.
49. Ran FA, PD Hsu, CY Lin, JS Gootenberg, S Konermann, AE Trevino,DAScott,AInoue, SMatoba,YZhang and F Zhang. (2013). Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154:1380-1389.
50. Mali P, J Aach, PB Stranges, KM Esvelt, M Moosburner, S Kosuri, L Yang and GM Church. (2013). CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat Biotechnol 31:833-838.
51. Tsai SQ, N Wyvekens, C Khayter, JA Foden, V Thapar, D Reyon, MJ Goodwin, MJ Aryee and JK Joung. (2014). Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat Biotechnol 32:569-576.
52. Guilinger JP, DB Thompson and DR Liu. (2014). Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat Biotechnol 32:577-582.
53. Seiler C,GDavuluri, JAbrams, FJ Byfield, PAJanmey andM Pack. (2012). Smooth muscle tension induces invasive remodeling of the zebrafish intestine. PLoS Biol 10:e1001386.
54. Baird GS, DA Zacharias and RY Tsien. (2000). Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc Natl Acad Sci USA 97:11984-11989.
55. Gilbert LA, MA Horlbeck, B Adamson, JE Villalta, Y Chen, EH Whitehead, C Guimaraes, B Panning, HL Ploegh, et al. (2014). Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159:647-661.
56. Konermann S, MD Brigham, AE Trevino, J Joung, OO Abudayyeh, C Barcena, PD Hsu, N Habib, JS Gootenberg, et al. (2015). Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517:583-588.
57. Chavez A, J Scheiman, S Vora, BW Pruitt, M Tuttle, PRE Iyer, S Lin, S Kiani, CD Guzman, et al. (2015). Highly efficient Cas9-mediated transcriptional programming. Nat Methods 12:326-328.
58. Ma Q, C Kintner and DJ Anderson. (1996). Identification of neurogenin, a vertebrate neuronal determination gene. Cell 87:43-52.
59. Fode C, G Gradwohl, X Morin, A Dierich, M LeMeur, C Goridis and F Guillemot. (1998). The bHLH protein NEUROGENIN 2 is a determination factor for epibranchial placode-derived sensory neurons. Neuron 20:483-494.
60. Fode C, Q Ma, S Casarosa, SL Ang, DJ Anderson and F Guillemot. (2000). A role for neural determination genes in specifying the dorsoventral identity of telencephalic neurons. Genes Dev 14:67-80.
61. Mizuguchi R, M Sugimori, H Takebayashi, H Kosako, M Nagao, S Yoshida, Y Nabeshima, K Shimamura and M Nakafuku. (2001). Combinatorial roles of olig2 and neurogenin2 in the coordinated induction of pan-neuronal and subtypespecific properties of motoneurons. Neuron 31:757-771.
62. Novitch BG, AI Chen and TM Jessell. (2001). Coordinate regulation ofmotor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron 31:773-789.
63. Scardigli R, C Schuurmans, G Gradwohl and F Guillemot. (2001). Crossregulation between Neurogenin2 and pathways specifying neuronal identity in the spinal cord. Neuron 31:203-217.
64. Dixit R, G Wilkinson, GI Cancino, T Shaker, L Adnani, S Li, D Dennis, D Kurrasch, JA Chan, et al. (2014). Neurog1 and neurog2 control two waves of neuronal differentiation in the piriform cortex. J Neurosci 34:539-553.
65. Roybon L, T Deierborg, P Brundin and JY Li. (2009). Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis. Eur J Neurosci 29:232-243.
66. Roybon L, T Hjalt, S Stott, F Guillemot, JY Li and P Brundin. (2009). Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis. PLoS One 4:e4779.
67. Ma Q, Z Chen, I del Barco Barrantes, JL de la Pompa and DJ Anderson. (1998). neurogenin1 is essential for the determination of neuronal precursors for proximal cranial sensory ganglia. Neuron 20:469-482.
68. Zirlinger M, L Lo, J McMahon, AP McMahon and DJ Anderson. (2002). Transient expression of the bHLH factor neurogenin-2 marks a subpopulation of neural crest cells biased for a sensory but not a neuronal fate. Proc Natl Acad Sci USA 99:8084-8089.
69. Hindley C, F Ali, G McDowell, K Cheng, A Jones, F Guillemot and A Philpott. (2012). Post-translational modification of Ngn2 differentially affects transcription of distinct targets to regulate the balance between progenitor maintenance and differentiation. Development 139:1718-1723.
70. Lee SK, B Lee, EC Ruiz and SL Pfaff. (2005). Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells. Genes Dev 19:282-294.
71. Shimizu T, M Nakazawa, S Kani, YK Bae, T Shimizu, R Kageyama and M Hibi. (2010). Zinc finger genes Fezf1 and Fezf2 control neuronal differentiation by repressing Hes5 expression in the forebrain. Development 137:1875-1885.
72. Busskamp V, NE Lewis, P Guye, AH Ng, SL Shipman, SM Byrne, NE Sanjana, J Murn, Y Li, et al. (2014). Rapid neurogenesis through transcriptional activation in human stem cells. Mol Syst Biol 10:760.
73. Berninger B, MR Costa, U Koch, T Schroeder, B Sutor, B Grothe and M Gotz. (2007). Functional properties of neurons derived from in vitro reprogrammed postnatal astroglia. J Neurosci 27:8654-8664.
74. Mazzoni EO, S Mahony, M Closser, CA Morrison, S Nedelec, DJ Williams, D An, DK Gifford and H Wichterle. (2013). Synergistic binding of transcription factors to cellspecific enhancers programs motor neuron identity. Nat Neurosci 16:1219-1227.
75. Liu ML, T Zang, Y Zou, JC Chang, JR Gibson, KM Huber and CL Zhang. (2013). Small molecules enable neurogenin 2 to efficiently convert human fibroblasts into cholinergic neurons. Nat Commun 4:2183.
76. Zhang Y, C Pak, Y Han, H Ahlenius, Z Zhang, S Chanda, S Marro, C Patzke, C Acuna, et al. (2013). Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78:785-798.
77. Perrin FE, G Boniface, C Serguera, N Lonjon, A Serre, M Prieto, J Mallet and A Privat. (2010). Grafted human embryonic progenitors expressing neurogenin-2 stimulate axonal sprouting and improve motor recovery after severe spinal cord injury. PLoS One 5:e15914.
78. Krentz NA, C Nian and FC Lynn. (2014). TALEN/CRISPR-mediated eGFP knock-in add-on at the OCT4 locus does not impact differentiation of human embryonic stem cells towards endoderm. PLoS One 9:e114275.